Form 8-K - Current report:
SEC Accession No. 0001193125-26-314167
Filing Date
2026-07-23
Accepted
2026-07-23 16:25:51
Documents
14
Period of Report
2026-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d143178d8k.htm   iXBRL 8-K 34348
2 EX-10.1 d143178dex101.htm EX-10.1 31187
3 EX-10.2 d143178dex102.htm EX-10.2 69116
4 EX-10.3 d143178dex103.htm EX-10.3 18904
  Complete submission text file 0001193125-26-314167.txt   313111

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ima-20260720.xsd EX-101.SCH 3193
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ima-20260720_lab.xml EX-101.LAB 18736
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ima-20260720_pre.xml EX-101.PRE 11717
18 EXTRACTED XBRL INSTANCE DOCUMENT d143178d8k_htm.xml XML 3789
Mailing Address 12526 HIGH BLUFF DRIVE SAN DIEGO CA 92130
Business Address 12526 HIGH BLUFF DRIVE SAN DIEGO CA 92130 857-343-8292
ImageneBio, Inc. (Filer) CIK: 0001835579 (see all company filings)

EIN.: 811697316 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 261197343
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)